- Sánchez-García, S.; Jaén, R.I.; Fernández-Velasco, M.; Delgado, C.; Boscá, L.; Prieto, P. "Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond.". Pharmacol Res. 197(): 106982. (2023). (PMID: 37925045).
 
- Povo-Retana, A.; Fariñas, M.; Landauro-Vera, R.; Mojena, M.; Alvarez-Lucena, C.; Fernández-Moreno, M.A.; Castrillo, A.; de la Rosa Medina, J.V.; Sánchez-García, S.; Foguet, C.; Mas, F.; Marin, S.; Cascante, M.; Boscá, L. "Immunometabolic actions of trabectedin and lurbinectedin on human macrophages: relevance for their anti-tumor activity.". Front Immunol. 14(): 1211068. (2023). (PMID: 37675104).
- Povo-Retana, A.; Landauro-Vera, R.; Fariñas, M.; Sánchez-García, S.; Alvarez-Lucena, C.; Marin, S.; Cascante, M.; Boscá, L. "Defining the metabolic signatures associated with human macrophage polarisation.". Biochem Soc Trans. (): . (2023). (PMID: 37449892).
- Povo-Retana, A.; Sánchez-García, S.; Alvarez-Lucena, C.; Landauro-Vera, R.; Prieto, P.; Delgado, C.; Martín-Sanz, P.; Boscá, L. "Crosstalk between P2Y receptors and cyclooxygenase activity in inflammation and tissue repair.". Purinergic Signal. (): . (2023). (PMID: 37052777).
- Paz-García, M.; Povo-Retana, A.; Jaén, R.I.; Prieto, P.; Peraza, D.A.; Zaragoza, C.; Hernandez-Jimenez, M.; Pineiro, D.; Regadera, J.; García-Bermejo, M.L.; Rodríguez-Serrano, E.M.; Sánchez-García, S.; Moro, M.A.; Lizasoaín, I.; Delgado, C.; Valenzuela, C.; Boscá, L. "Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarction.". Biomed Pharmacother. 158(): 114214. (2023). (PMID: 36916435).
|
Email:Info